![region x osha training region x osha training](https://www.beaconmutual.com/assets/OSHA-Update-Area-Director-930x535.jpg)
![region x osha training region x osha training](https://facilityresults.com/wp-content/uploads/2019/08/2.png)
Use the Site-Specific Training checklist located within the course content to review site-specific training items with your supervisor or designated work area trainer. To finish your training requirement, you must also know specific information unique to your own work area. This course is required initially for at risk workers.Audience: Individuals in Facilities Management and University Housing and Dining at risk for BBP exposure.This course is required initially and annually for at risk workers. To finish your training requirement, you must also know specific information unique to your own work area.Audience: Facilities Management personnel who perform maintenance and/or moving services for laboratory equipment.īloodborne Pathogens (BBP) for FM, Housing & Dining Employees - W518BO.A requirement for annual completion may be set by the individual’s department and/or supervisor. This course is required initially and recommended annually for the indicated audience.The course is also recommended for individuals using a clean bench in order to explain the limitations of the equipment. Audience: Individuals who handle biological agents in a research lab or other work area and use a biological safety cabinet (tissue culture hood) to limit exposure to potentially infectious agents and/or for product protection.This course is recommended initially and annually for the indicated audience.Audience: All individuals working in a lab space where biological agents are likely to be present.This course is required initially and recommended annually for the indicated audience.Audience: Lab personnel working with organisms that present a higher hazard level to themselves or others, e.g., viral vectors, S.This course is required initially for individuals working with organisms that would be classified as Risk Group 2 (moderate-risk agents associated with human disease that is rarely serious and for which preventive or therapeutic interventions are often available) or higher.